Preview: ADMA Biologics's Earnings

ADMA Biologics (NASDAQ:ADMA) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-25. Here's a quick overview of what investors should know before the release.

Analysts are estimating that ADMA Biologics will report an earnings per share (EPS) of $0.20.

Investors in ADMA Biologics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Past Earnings Performance

The company's EPS missed by $0.00 in the last quarter, leading to a 8.72% drop in the share price on the following day.

Here's a look at ADMA Biologics's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.16	0.14	0.14	0.15
EPS Actual	0.16	0.14	0.14	0.14
Price Change %	-9.00	-10.00	-10.00	7.00

Performance of ADMA Biologics Shares

Shares of ADMA Biologics were trading at $16.29 as of February 23. Over the last 52-week period, shares are up 0.76%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for ADMA Biologics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.